Skip to main content
. Author manuscript; available in PMC: 2011 Apr 11.
Published in final edited form as: Chemistry. 2009 Sep 7;15(35):8670–8676. doi: 10.1002/chem.200900821

Figure 5.

Figure 5

(left) ACE active site showing the association of lisinopril (inhibitor) with enzyme sub-sites. (right) A schematic illustration of the proposed mechanism of action. A bound metallopeptide activates dioxygen and the resulting reactive oxygen species mediates irreversible damage to the target enzyme.